Literature DB >> 32253208

Development of Probiotic Formulations for Oral Candidiasis Prevention: Gellan Gum as a Carrier To Deliver Lactobacillus paracasei 28.4.

Felipe de Camargo Ribeiro1, Juliana Campos Junqueira2, Jéssica Diane Dos Santos1, Patrícia Pimentel de Barros1, Rodnei Dennis Rossoni1, Shashank Shukla3, Beth Burgwyn Fuchs4, Anita Shukla3, Eleftherios Mylonakis4.   

Abstract

Probiotics might provide an alternative approach for the control of oral candidiasis. However, studies on the antifungal activity of probiotics in the oral cavity are based on the consumption of yogurt or other dietary products, and it is necessary to use appropriate biomaterials and specific strains to obtain probiotic formulations targeted for local oral administration. In this study, we impregnated gellan gum, a natural biopolymer used as a food additive, with a probiotic and investigated its antifungal activity against Candida albicans Lactobacillus paracasei 28.4, a strain recently isolated from the oral cavity of a caries-free individual, was incorporated in several concentrations of gellan gum (0.6% to 1% [wt/vol]). All tested concentrations could incorporate L. paracasei cells while maintaining bacterial viability. Probiotic-gellan gum formulations were stable for 7 days when stored at room temperature or 4°C. Long-term storage of bacterium-impregnated gellan gum was achieved when L. paracasei 28.4 was lyophilized. The probiotic-gellan gum formulations provided a release of L. paracasei cells over 24 h that was sufficient to inhibit the growth of C. albicans, with effects dependent on the cell concentrations incorporated into gellan gum. The probiotic-gellan gum formulations also had inhibitory activity against Candida sp. biofilms by reducing the number of Candida sp. cells (P < 0.0001), decreasing the total biomass (P = 0.0003), and impairing hyphae formation (P = 0.0002), compared to the control group which received no treatment. Interestingly, a probiotic formulation of 1% (wt/vol) gellan gum provided an oral colonization of L. paracasei in mice with approximately 6 log CFU/ml after 10 days. This formulation inhibited C. albicans growth (P < 0.0001), prevented the development of candidiasis lesions (P = 0.0013), and suppressed inflammation (P = 0.0006) compared to the mice not treated in the microscopic analysis of the tongue dorsum. These results indicate that gellan gum is a promising biomaterial and can be used as a carrier system to promote oral colonization for probiotics that prevent oral candidiasis.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Candida albicans; Lactobacillus paracasei; gellan gum; hydrogels; oral candidiasis

Mesh:

Substances:

Year:  2020        PMID: 32253208      PMCID: PMC7269487          DOI: 10.1128/AAC.02323-19

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  51 in total

1.  Oral sustained delivery of paracetamol from in situ-gelling gellan and sodium alginate formulations.

Authors:  Wataru Kubo; Shozo Miyazaki; David Attwood
Journal:  Int J Pharm       Date:  2003-06-04       Impact factor: 5.875

Review 2.  Probiotics and oral health: an update.

Authors:  K Pradeep; M A Kuttappa; K R Prasana
Journal:  SADJ       Date:  2014-02

3.  Enhancing the viability of Lactobacillus rhamnosus GG after spray drying and during storage.

Authors:  Géraldine Broeckx; Dieter Vandenheuvel; Tim Henkens; Shari Kiekens; Marianne F L van den Broek; Sarah Lebeer; Filip Kiekens
Journal:  Int J Pharm       Date:  2017-10-03       Impact factor: 5.875

4.  Lactobacillus paracasei 28.4 reduces in vitro hyphae formation of Candida albicans and prevents the filamentation in an experimental model of Caenorhabditis elegans.

Authors:  Patrícia Pimentel de Barros; Liliana Scorzoni; Felipe de Camargo Ribeiro; Luciana Ruano de Oliveira Fugisaki; Beth Burgwyn Fuchs; Eleftherios Mylonakis; Antonio Olavo Cardoso Jorge; Juliana Campos Junqueira; Rodnei Dennis Rossoni
Journal:  Microb Pathog       Date:  2018-02-09       Impact factor: 3.738

5.  Enhanced clearance of Candida albicans from the oral cavities of mice following oral administration of Lactobacillus acidophilus.

Authors:  S Elahi; G Pang; R Ashman; R Clancy
Journal:  Clin Exp Immunol       Date:  2005-07       Impact factor: 4.330

6.  Tunable antibiotic delivery from gellan hydrogels.

Authors:  Shashank Shukla; Anita Shukla
Journal:  J Mater Chem B       Date:  2018-09-19       Impact factor: 6.331

7.  Photodynamic therapy for the treatment of buccal candidiasis in rats.

Authors:  Juliana Campos Junqueira; Joyce da Silva Martins; Raquel Lourdes Faria; Carlos Eduardo Dias Colombo; Antonio Olavo Cardoso Jorge
Journal:  Lasers Med Sci       Date:  2009-05-01       Impact factor: 3.161

8.  Antifungal activity of clinical Lactobacillus strains against Candida albicans biofilms: identification of potential probiotic candidates to prevent oral candidiasis.

Authors:  Rodnei Dennis Rossoni; Patrícia Pimentel de Barros; Janaina Araújo de Alvarenga; Felipe de Camargo Ribeiro; Marisol Dos Santos Velloso; Beth Burgwyn Fuchs; Eleftherios Mylonakis; Antonio Olavo Cardoso Jorge; Juliana Campos Junqueira
Journal:  Biofouling       Date:  2018-01-30       Impact factor: 3.209

Review 9.  Current strategies for prevention of oral manifestations of human immunodeficiency virus.

Authors:  Lauren L Patton
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2015-09-09

10.  Synbiotic therapy decreases microbial translocation and inflammation and improves immunological status in HIV-infected patients: a double-blind randomized controlled pilot trial.

Authors:  Luz A González-Hernández; Luis F Jave-Suarez; Mary Fafutis-Morris; Karina E Montes-Salcedo; Luis G Valle-Gutierrez; Ariel E Campos-Loza; Luis Fermin Enciso-Gómez; Jaime F Andrade-Villanueva
Journal:  Nutr J       Date:  2012-10-29       Impact factor: 3.271

View more
  5 in total

1.  Ozonated oil is effective at killing Candida species and Streptococcus mutans biofilm-derived cells under aerobic and microaerobic conditions.

Authors:  Barbara Higa; Bianca Souza Cintra; Carmen Magaly Álvarez; Arthur Barcelos Ribeiro; Jair Camargo Ferreira; Denise Crispim Tavares; Vanessa Enriquez; Luis R Martinez; Regina Helena Pires
Journal:  Med Mycol       Date:  2022-08-08       Impact factor: 3.747

2.  In Vivo Efficacy of Lacticaseibacillus rhamnosus L8020 in a Mouse Model of Oral Candidiasis.

Authors:  Rei Ito; Yuichi Mine; Yoshie Yumisashi; Reina Yoshioka; Misa Hamaoka; Tsuyoshi Taji; Takeshi Murayama; Hiroki Nikawa
Journal:  J Fungi (Basel)       Date:  2021-04-21

Review 3.  Molecular Mapping of Antifungal Mechanisms Accessing Biomaterials and New Agents to Target Oral Candidiasis.

Authors:  Valentina Anuța; Marina-Theodora Talianu; Cristina-Elena Dinu-Pîrvu; Mihaela Violeta Ghica; Răzvan Mihai Prisada; Mădălina Georgiana Albu Kaya; Lăcrămioara Popa
Journal:  Int J Mol Sci       Date:  2022-07-07       Impact factor: 6.208

4.  Probiotic Effects of Lactobacillus paracasei 28.4 to Inhibit Streptococcus mutans in a Gellan-Based Formulation.

Authors:  Janaína Araújo de Alvarenga; Patrícia Pimentel de Barros; Felipe de Camargo Ribeiro; Rodnei Dennis Rossoni; Maíra Terra Garcia; Marisol Dos Santos Velloso; Shashank Shukla; Beth Burgwyn Fuchs; Anita Shukla; Eleftherios Mylonakis; Juliana Campos Junqueira
Journal:  Probiotics Antimicrob Proteins       Date:  2020-09-27       Impact factor: 4.609

5.  The Postbiotic Activity of Lactobacillus paracasei 28.4 Against Candida auris.

Authors:  Rodnei Dennis Rossoni; Patrícia Pimentel de Barros; Iatã do Carmo Mendonça; Rebeca Previate Medina; Dulce Helena Siqueira Silva; Beth Burgwyn Fuchs; Juliana Campos Junqueira; Eleftherios Mylonakis
Journal:  Front Cell Infect Microbiol       Date:  2020-08-04       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.